Breaking Income Disparity Affects Youth Sports Participation, Poll Finds Former Republican David Jolly Launches Democratic Bid for Florida Governor Cuba Marks Fidel Castro’s Centennial Amidst Economic Woes and Divided Legacy Crown Prince Akishino Expresses Mixed Feelings on Imperial House Law Revision Taiwan Tests Civilian Resilience with Mobile Data Reduction During Military Drills

Thursday August 13, 2026

Reporter

Kye Pharmaceuticals Inc.

1Articles Published

4Communities Covered

Published Articles

Press Release

SLENYTO® (melatonin extended-release tablets) is now available in Canada as a prescription treatment for insomnia in children and adolescents with autism spectrum disorder (ASD) and/or Smith-Magenis syndrome (SMS).

Aug 11